| ALL | Acute Lymphocytic Leukemia |
| AML | Acute Myeloid Leukemia |
| B-ALL | B-cell Acute Lymphocytic Leukemia |
| cALL | Children Acute Lymphocytic Leukemia |
| CAR | Chimeric Antigen Receptor |
| CH | Clonal Hematopoiesis |
| CLL | Chronic Lymphocytic Leukemia |
| CML | Chronic Myelogenous Leukemia |
| CMML | Chronic Myelomonocytic leukemia |
| CN | Congenital Neutropenia |
| CTCL | Cutaneous T-cell Lymphoma |
| DLBCL | Diffuse Large B Cell Lymphoma |
| DS-ML | Down Syndrome-Myeloid Leukemia |
| ET | Essential Thrombocythemia |
| FPD/AML | Familial Platelet Disorder/Acute Myeloid Leukemia |
| GM-CSF | Granulocyte-Macrophage Colony-Stimulating Factor |
| HGBCL | High-grade B-cell Lymphoma |
| hnCD16 | High-affinity, Non-cleavable CD16 Fc receptor |
| HSC | Hematopoietic Stem Cells |
| HSPC | Hematopoietic Stem and Progenitor Cells |
| IL15RF | Interleukin 15 Receptor Fusion |
| iPSC | Induced Pluripotent Stem Cells |
| JMML | Juvenile Myelomonocytic leukemia |
| LSC | Leukemic Stem Cells |
| mAB | Monoclonal Antibody |
| MDS | Myelodysplastic Syndrome |
| MGUS | Monoclonal Gammopathy of Undetermined Significance |
| MM | Multiple Myeloma |
| MPN | Myeloproliferative Neoplasm |
| NHL | Non-Hodgkin Lymphoma |
| NK | Natural Killer Cells |
| NS/JMML | Noonan Syndrome/Juvenile Myelomonocytic Leukemia |
| NSG | NOD SCID IL2Rgnull |
| PTCL | Peripheral T-cell Lymphoma |
| PV | Polycythemia Vera |
| TKI | Tyrosine Kinase Inhibitors |
| TMD | Transient Myeloproliferative Disorder |